RNA Ligase Market: RNA Ligation, Sequencing Library Prep, and Growth Outlook 2026–2032

Global Leading Market Research Publisher QYResearch announces the release of its latest report “RNA Ligase – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global RNA Ligase market, including market size, share, demand, industry development status, and forecasts for the next few years.

For molecular biologists, NGS core facility managers, and synthetic biology researchers, joining RNA fragments or circularizing RNA molecules is essential for library preparation, RNA repair, and probe construction. RNA ligase addresses this as enzymes that catalyze phosphodiester bond formation between two RNA molecules or within a single RNA strand. Playing vital roles in RNA repair, RNA interference, small RNA sequencing library construction, RNA labeling, and molecular probe preparation, RNA ligases are indispensable tools in high-throughput sequencing, noncoding RNA research, and synthetic biology. Based on source and function, they include T4 RNA ligase 1 (single-stranded RNA or RNA-DNA ligation) and T4 RNA ligase 2 (double-stranded RNA end joining), typically relying on ATP as an energy source.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6098343/rna-ligase

Market Size and Growth Fundamentals

The global RNA ligase market was valued at US$ 83.77 million in 2025 and is projected to reach US$ 112 million by 2032, growing at a CAGR of 4.3% from 2026 to 2032. Growth is driven by expanding next-generation sequencing (NGS) applications, increasing RNA-based research, and demand for RNA ligases in synthetic biology and molecular diagnostics.

Product Overview and Enzyme Types

RNA ligase enzymes are classified by their substrate preference and ligation mechanism:

• T4 RNA Ligase 1: Catalyzes ligation of single-stranded RNA or RNA-DNA hybrids. Requires ATP as cofactor. Preferred for small RNA (miRNA, piRNA) library preparation, RNA labeling, and circularization of single-stranded RNA.
• T4 RNA Ligase 2: Prefers joining double-stranded RNA ends with nicks or gaps. Requires ATP. Preferred for double-stranded RNA ligation, small RNA sequencing (3′ and 5′ adapter ligation), and RNA repair applications where double-strand specificity reduces background.
• Other: Engineered variants and ligases from alternative sources (e.g., bacteriophage, bacterial) with specialized properties (thermostability, high efficiency for specific substrates).

Key applications by enzyme type:

• T4 RNA Ligase 1: Small RNA sequencing library construction, 3′ end labeling, RNA circularization
• T4 RNA Ligase 2: Small RNA library preparation (reduced adapter-dimer formation), double-stranded RNA ligation
• Specialty Ligases: High-throughput automation, ligation of modified RNA, thermostable reactions

Market Segmentation: Enzyme Types and Applications

The RNA ligase market is segmented by enzyme type into:

• T4 RNA Ligase 2: Largest segment (approximately 45% of market value), preferred for small RNA sequencing due to lower adapter-dimer background.
• T4 RNA Ligase 1: Significant segment for general RNA ligation and 3′ end labeling applications.
• Other: Engineered variants and alternative sources; fastest-growing for specialized applications.

By application, the market spans Molecular Biology, High-throughput Sequencing, RNA Repair and Synthetic Biology, Medicine and Drug Discovery, and Other:

• High-throughput Sequencing: Largest segment (approximately 40%), driven by small RNA-seq, total RNA-seq, and single-cell RNA-seq library preparation
• Molecular Biology: Routine cloning, RNA labeling, and probe preparation
• RNA Repair and Synthetic Biology: RNA splicing studies, ribozyme engineering, synthetic RNA circuits
• Medicine and Drug Discovery: RNA therapeutics development, RNA-based diagnostics

Competitive Landscape: Key Players

The RNA ligase market features global molecular biology reagent suppliers and specialized enzyme manufacturers:

Recent Developments (Last 6 Months)

Several developments have shaped the RNA ligase market:

• NGS Market Growth: December 2025–January 2026 saw continued expansion of NGS applications (single-cell RNA-seq, spatial transcriptomics, small RNA discovery), driving demand for RNA ligases in library preparation workflows.
• RNA Therapeutics: Growth in RNA therapeutics (mRNA vaccines, RNAi drugs, antisense oligonucleotides) increased demand for RNA ligases in manufacturing and quality control.
• Engineered Variants: Introduction of thermostable and high-efficiency RNA ligase variants for automated library preparation and challenging substrates.
• Small RNA Discovery: Increased focus on noncoding RNA biomarkers (miRNA, piRNA, circRNA) in cancer and disease research drove demand for small RNA-seq library preparation.

Exclusive Insight: T4 RNA Ligase 1 vs. T4 RNA Ligase 2—Substrate Specificity Drives Selection

A critical market dynamic is the divergence between T4 RNA Ligase 1 and T4 RNA Ligase 2 based on substrate and application requirements.

T4 RNA Ligase 1 (established segment) is characterized by:

• Substrate: Single-stranded RNA or RNA-DNA hybrids
• Primary Use: 3′ end labeling, RNA circularization, general RNA ligation
• Limitation: Higher adapter-dimer background in NGS library prep
• Applications: Molecular biology, RNA structure studies, probe preparation

T4 RNA Ligase 2 (largest segment for NGS) is characterized by:

• Substrate: Double-stranded RNA ends with nicks or gaps
• Primary Use: Small RNA-seq library construction (reduced adapter-dimer)
• Advantage: Lower background, higher specificity for RNA ends
• Applications: Small RNA sequencing, miRNA discovery, RNA repair

Engineered Variants (fastest-growing) are characterized by:

• Thermostability: Active at higher temperatures for challenging structures
• High Efficiency: Faster ligation kinetics for automation
• Modified Substrate Compatibility: Ligation of chemically modified RNA
• Applications: High-throughput sequencing, RNA therapeutics, synthetic biology

A 2026 industry analysis indicated that T4 RNA Ligase 2 is preferred for NGS library preparation where low background is critical. T4 RNA Ligase 1 remains standard for general molecular biology applications.

Technical Challenges and Innovation Directions

Key technical considerations in RNA ligase development include:

• Substrate Specificity: Balancing efficiency with specificity to minimize off-target ligation
• Adapter-Dimer Formation: Reducing self-ligation of adapters in NGS library prep
• Modified RNA: Efficient ligation of chemically modified RNA (e.g., 2′-O-methyl, locked nucleic acids)
• High-Throughput Compatibility: Automation-friendly formats and reaction conditions

Innovation focuses on:

• Engineered Ligases: Directed evolution for improved activity and specificity
• Thermostable Variants: Ligation at elevated temperatures for structured RNA
• One-Pot Reactions: Combined ligation and reverse transcription workflows
• Magnetic Bead-Based Cleanup: Simplified library preparation protocols

Conclusion

The RNA ligase market is positioned for steady growth through 2032, driven by NGS expansion, RNA therapeutics, and increasing RNA-based research. For manufacturers, success will depend on enzyme purity, substrate specificity, and integration with library preparation workflows. As RNA sequencing and RNA-based technologies continue to advance, RNA ligases will remain essential tools for molecular biology, diagnostics, and synthetic biology.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp